Virtual Pharma R&D: Open For Business

In Vivo

Open, or virtual, R&D is a current reality but could pharmaceutical companies embrace it more completely and execute it differently to deliver more substantial benefits? Charles River Associates looks to other industries to identify six drivers for success.